Claritev (NYSE:CTEV) reported quarterly losses of $(4.41) per share which missed the analyst consensus estimate of $(3.85) by 14.55 percent. This is a 0.68 percent decrease over losses of $(4.38) per share from the same period last year. The company reported quarterly sales of $244.678 million which beat the analyst consensus estimate of $236.389 million by 3.51 percent. This is a 5.77 percent increase over sales of $231.330 million the same period last year.